In patients with stage I lung adenocarcinoma, tumor budding is a significant prognostic factor for recurrence, independent of the IASLC/ATS/ERS classification, and correlates with a protumor immune microenvironment Meeting Abstract


Authors: Kadota, K.; Yeh, Y. C.; Rizk, N. P.; Rusch, V. W.; Adusumilli, P. S.; Travis, W. D.
Abstract Title: In patients with stage I lung adenocarcinoma, tumor budding is a significant prognostic factor for recurrence, independent of the IASLC/ATS/ERS classification, and correlates with a protumor immune microenvironment
Meeting Title: 15th World Conference on Lung Cancer (IASLC)
Keywords: adenocarcinoma; recurrence; lung; tumor budding
Journal Title: Journal of Thoracic Oncology
Volume: 8
Issue: Suppl. 2
Meeting Dates: 2013 Oct 27-31
Meeting Location: Sydney, Australia
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2013-11-01
Start Page: S415
Language: English
ACCESSION: WOS:000339624902022
PROVIDER: wos
DOI: 10.1097/01.JTO.0000438438.14562.c8
Notes: Meeting Abstract: MO26.03 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Valerie W Rusch
    864 Rusch
  2. Nabil Rizk
    139 Rizk
  3. William D Travis
    743 Travis
  4. Kyuichi Kadota
    85 Kadota
  5. Yi-Chen Yeh
    10 Yeh